CHNA
Loncar China BioPharma ETF
CHNA
CHNA
Delisted
CHNA was delisted on the 20th of October, 2023.
3 hedge funds and large institutions have $948K invested in Loncar China BioPharma ETF in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
3
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 | -$888K | |
| 2 | -$45K | |
| 3 | -$25.8K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$11K |
| 5 |
Citigroup
New York
|
-$9K |